Summary The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded Mennonite General Hospital, Inc. (MGHPR) a $7.5M Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program on September 30, 2025. The HEP C FREE Puerto Rico Integrated Care Pilot will deliver comprehensive hepatitis C (HCV) screening, testing, and treatment services to 10,000 high-risk adults...
Federal Project Grant Award Summary Gandara Mental Health Center Inc. received a $850,000 Project Grant award effective September 30, 2025, through September 29, 2030, from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The award supports the expansion and strengthening of the Stop Access Community Coalition (SAC), an established community-based...
Federal Project Grant Award Summary Fenway Community Health Center, Inc. received a $2.12 million cooperative agreement award from the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau under the Special Projects of National Significance (SPNS) program (CFDA 93.928), effective August 1, 2025, through August 31, 2029. This award supports the development and implementation of innovative HIV care and treatment models designed to address emerging needs of Ryan White HIV/AIDS Program...
Federal Grant Award Summary Brockton Neighborhood Health Center, Inc. received a $300,000 project grant award effective September 1, 2025, through August 31, 2026, from the Health Resources and Services Administration (HRSA) under the HIV-Related Training and Technical Assistance program (CFDA 93.145). The award supports the center's Ryan White HIV/AIDS Program Part C Capacity Development initiative focused on improving social determinants of health (SDOH) screening for people living with HIV...
Portland Community Health Center (PCHC), doing business as Greater Portland Health, received a $210,000 Project Grant award from the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the period September 1, 2025, through August 31, 2026. As the sole Ryan White Part C provider in Greater Portland, Maine's most populous region, PCHC will deliver capacity development and process improvement...
The University of Massachusetts Lowell received a $1.69 million Project Grant from the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau under the Special Projects of National Significance (SPNS) program (CFDA 93.928) for the period August 1, 2025 through July 31, 2029. Under this cooperative agreement, the university is developing and implementing innovative HIV care and treatment models designed to address emerging needs of Ryan White HIV/AIDS Program (RWHAP) clients. The...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 1, 2026 through February 28, 2030. This four-year research initiative will deliver clinical outcomes research and health economic analysis examining the integration of infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The...
Federal Grant Award Summary Bienestar Human Services, Inc. received a $5.0 million Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243), awarded on September 30, 2025, with a completion date of September 29, 2027. The grant supports an HCV Elimination and Integrated Care initiative serving high-need communities across Los Angeles County,...
Federal Project Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. This mentored research career development award supports a mixed-methods study leveraging Massachusetts' statewide Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program as a natural experiment. The research will...
Federal Project Grant Award Summary Baystate Medical Center, Inc. received a $905,970 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, with completion targeted for August 31, 2026. The award supports the development and testing of Relational Health Enhanced Parenting Support (RHEP), a multilevel implementation strategy bundle designed to improve the delivery of evidence-based parenting...
PROJECT HEALTH - THE GANDARA (GC) PROJECT HEALTH/PROJECTO SALUD (PH/PS) PROGRAM INTEGRATES PRIMARY AND INFECTIOUS DISEASE CARE WITHIN A HISPANIC, MINORITY-FOCUSED BEHAVIORAL HEALTH CLINIC (MH/SUD) WITH THE CLEAR AIM TO PROVIDE HIV/HCV PREVENTION AND TREATMENT COORDINATION TO INDIVIDUALS WITH HIGH SOCIAL AND HEALTH DISPARITIES IN SPRINGFIELD, MA. THE PROJECT IS BASED ON THE PRINCIPLES OF INTEGRATING SOCIAL NEEDS INTO HEALTH CARE INCLUDING CLEAR AIM, MODEL TESTING AND CEDE CONTROL. THE POPULATION OF FOCUS IS PRIMARILY HISPANIC MINORITIES WITH SUD, SMI, DOD WHO ARE AT THE HIGH RISK OF CONTRACTING, OR ARE LIVING WITH HIV/AIDS OR HEPATITIS. NEARLY 5000 INDIVIDUALS ARE SERVED AT THE CLINICS ANNUALLY (73% HISPANIC OR MIXED RACE, 74% NON-WHITE, WOMEN 45%, MEN 54%). APPROXIMATELY 2,500 PEOPLE MEET THE TARGET ELIGIBILITY CRITERIA. THE PROGRAM IS EMBEDDED WITHIN OUR MINORITY FOCUSED, COMMUNITY-BASED OUTPATIENT CLINIC. GANDARA'S CLEAR AIM IS TO FULLY ADDRESS THE CULTURAL, ACCESS, AND CARE COORDINATION BARRIERS EXPERIENCED BY MANY HIGH NEEDS HISPANIC/OTHER MINORITY INDIVIDUALS WITH COMPLEX MEDICAL AND BH CARE NEEDS BY EXPANDING OUR EXISTING MULTI-DISCIPLINARY COORDINATED CARE SETTING THAT OFFERS INDIVIDUALS AN ARRAY OF SERVICES AT DELIVERED BY AN INTEGRATED, BILINGUAL TEAM OF STAFF. THE PH/PS INTEGRATED CARE TEAM WILL BE LED BY AN EXPERIENCED NURSE CASE MANAGER, AND CONSIST OF OUTREACH CASE MANAGERS, PEER RECOVERY SUPPORT SPECIALISTS, SUBSTANCE USE CLINICIANS, AND PRIMARY INFECTIOUS DISEASE CARE (THROUGH AN ESTABLISHED PARTNERSHIP). THE PROGRAM WILL PROVIDE BOTH INTERNAL AND EXTERNAL COMMUNITY OUTREACH, ENGAGEMENT, AND EDUCATION, COMPREHENSIVE CASE MANAGEMENT, SUD TREATMENT, AND INFECTIOUS DISEASE TREATMENT AND PREVENTION. THE UTILIZATION OF MOTIVATIONAL INTERVIEWING (MI) AND STAGES OF CHANGE FACILITATES SUCCESSFUL ENGAGEMENT AND A COLLABORATIVE TREATMENT EFFORT. AN OUTREACH/CASE MANAGER/PEER TEAM SUPPORTS INDIVIDUAL GOAL SETTING/ACHIEVEMENT AND LINKAGES TO COMMUNITY SERVICES- MAT, ADHERENCE SUPPORT, OTHER MEDICAL AND DENTAL, BENEFITS, HOUSING, RECOVERY AND RELAPSE PREVENTION, VOCATIONAL/EMPLOYMENT PLACEMENT, AND WELLNESS SERVICES. CORE GOALS /MEASURABLE OBJECTIVES INCLUDE 1) REDUCE THE INCIDENCE OF HIV/AIDS AND HEP AND IMPROVE OVERALL HEALTH OUTCOMES FOR INDIVIDUALS WITH SUD OR CO-OCCURRING DISORDER (COD) VIA INCREASED ENGAGEMENT WITH CARE, USE OF CULTURALLY COMPETENT SUD TREATMENT WITH HIV/HEP PRIMARY CARE, PREVENTION SERVICES, SCREENING FOR INDIVIDUALS WITH SUD/COD LIVING WITH OR AT RISK FOR HIV/AIDS. 2) DELIVER COMPREHENSIVE SERVICES, THROUGH AN INFECTIOUS DISEASE COOPERATIVE CARE TEAM LED BY A NURSE CASE MANAGER FOR INDIVIDUALS WITH SUD/COD, INCLUDING INFECTIOUS DISEASE PRIMARY CARE, PSYCHIATRY, RN PRESCRIBERS, SUD CLINICIANS, OUTREACH/CASE MANAGERS(CM), PEER/ RECOVERY COACHES AND SERVICE LINKAGES TO INCREASE PHYSICAL/ RECOVERY STABILITY OUTCOMES. 3) BUILD A SYSTEM TO TRACK COORDINATED LINKAGES TO TREATMENT, RECOVERY SERVICES AND OTHER WRAPAROUND SUPPORTS, AS WELL AS PARTICIPANT ACCESS TO SERVICES, TO IMPLEMENT AN INTEGRATED TREATMENT MODEL THAT PROMOTES OVERALL HEALTH AND WELLNESS STABILITY 4) IMPLEMENT THE PROGRAM EVALUATION PLAN TO DETERMINE WHETHER PROGRAM GOALS, OBJECTIVES, AND OUTCOMES HAVE BEEN ACHIEVED AND WHETHER ADJUSTMENTS TO PROGRAMMING AND WORKFLOWS ARE NEEDED. NUMBERS SERVED 500 INDIVIDUALS ACROSS THE 5 YEARS, Y1 90, Y2 110, Y3 110, AND Y4 100. INDIVIDUALS RECEIVING ANNUAL ENHANCED RISK SCREENING 1500, PREVENTION/EDUCATION 750 RAPID TESTING: 600.